An Efficacy Study of Canagliflozin or Sitagliptin to Determine Glucose Variability in Mexican Participants With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin
Condition: Diabetes Mellitus, Type 2 Interventions: Drug: Canagliflozin 300 mg; Drug: Sitagliptin 100 mg; Drug: Metformin Sponsor: Janssen Research & Development, LLC Not yet recruiting - verified September 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2017 Category: Research Source Type: clinical trials
An Efficacy Study of Canagliflozin or Sitagliptin to Determine Glucose Variability in Mexican Participants With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin
Condition: Diabetes Mellitus, Type 2 Interventions: Drug: Canagliflozin 300 mg; Drug: Sitagliptin 100 mg; Drug: Metformin Sponsor: Janssen Research & Development, LLC Not yet recruiting - verified August 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2017 Category: Research Source Type: clinical trials
Safety and Efficacy of Bexagliflozin Compared to Sitagliptin as Add-on Therapy to Metformin in Type 2 Diabetes Subjects
Condition: Type 2 Diabetes Mellitus Interventions: Drug: Bexagliflozin; Drug: Sitagliptin; Drug: Placebo for sitagliptin; Drug: Placebo for bexagliflozin Sponsor: Theracos Not yet recruiting - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2017 Category: Research Source Type: clinical trials